CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | +6.7% | 495 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $30,000 | +20.0% | 495 | +25.3% | 0.00% | 0.0% |
| Q1 2022 | $25,000 | -16.7% | 395 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $30,000 | -31.8% | 395 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -31.2% | 395 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $64,000 | +33.3% | 395 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $48,000 | -20.0% | 395 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $60,000 | +81.8% | 395 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $33,000 | +13.8% | 395 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $29,000 | +81.2% | 395 | +5.3% | 0.00% | +100.0% |
| Q1 2020 | $16,000 | -54.3% | 375 | -34.8% | 0.00% | -50.0% |
| Q4 2019 | $35,000 | +45.8% | 575 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $24,000 | -11.1% | 575 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $27,000 | +28.6% | 575 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $21,000 | +31.2% | 575 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $16,000 | -38.5% | 575 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $26,000 | +18.2% | 575 | +53.3% | 0.00% | +100.0% |
| Q2 2018 | $22,000 | +29.4% | 375 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $17,000 | +240.0% | 375 | +87.5% | 0.00% | – |
| Q4 2017 | $5,000 | +25.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |